Display options
Cite
Raval YS, Mohamed A, Zmuda HM, et al. Hydrogen-Peroxide-Generating Electrochemical Scaffold Eradicates Methicillin-Resistant . Glob Chall. 2019;3(6):1800101doi: 10.1002/gch2.201800101.
Raval, Y. S., Mohamed, A., Zmuda, H. M., Patel, R., & Beyenal, H. (2019). Hydrogen-Peroxide-Generating Electrochemical Scaffold Eradicates Methicillin-Resistant . Global challenges (Hoboken, NJ), 3(6), 1800101. https://doi.org/10.1002/gch2.201800101
Raval, Yash S, et al. "Hydrogen-Peroxide-Generating Electrochemical Scaffold Eradicates Methicillin-Resistant ." Global challenges (Hoboken, NJ) vol. 3,6 (2019): 1800101. doi: https://doi.org/10.1002/gch2.201800101
Raval YS, Mohamed A, Zmuda HM, Patel R, Beyenal H. Hydrogen-Peroxide-Generating Electrochemical Scaffold Eradicates Methicillin-Resistant . Glob Chall. 2019 Mar 06;3(6):1800101. doi: 10.1002/gch2.201800101. eCollection 2019 Jun. PMID: 31218078; PMCID: PMC6551415.
Copy Download .nbib Format: NLM
Share it on

Glob Chall. 2019 Mar 06;3(6):1800101. doi: 10.1002/gch2.201800101. eCollection 2019 Jun.

Hydrogen-Peroxide-Generating Electrochemical Scaffold Eradicates Methicillin-Resistant .

Global challenges (Hoboken, NJ)

Yash S Raval, Abdelrhman Mohamed, Hannah M Zmuda, Robin Patel, Haluk Beyenal

Affiliations

  1. Division of Clinical Microbiology Mayo Clinic Rochester MN 55905 USA.
  2. The Gene and Voiland School of Chemical Engineering and Bioengineering Washington State University Pullman WA 99164 USA.
  3. Division of Infectious Diseases Mayo Clinic Rochester MN 55905 USA.

PMID: 31218078 PMCID: PMC6551415 DOI: 10.1002/gch2.201800101

Abstract

Increasing rates of chronic wound infections caused by antibiotic-resistant bacteria are a crisis in healthcare settings. Biofilms formed by bacterial communities in these wounds create a complex environment, enabling bacteria to persist, even with antibiotic treatment. Wound infections caused by methicillin-resistant

Keywords: H2O2; MRSA; biofilms; electrochemical; e‐scaffolds

Conflict of interest statement

RP reports grants from CD Diagnostics, BioFire, Curetis, Merck, Hutchison Biofilm Medical Solutions, Accelerate Diagnostics, Allergan, and The Medicines Company. consultant to Curetis, Qvella, St. Jud

References

  1. Am J Surg. 1968 May;115(5):683-7 - PubMed
  2. Int Wound J. 2009 Dec;6(6):420-30 - PubMed
  3. Chem Biol. 2013 Sep 19;20(9):1168-78 - PubMed
  4. J Bacteriol. 2008 Aug;190(15):5493-501 - PubMed
  5. Antimicrob Agents Chemother. 2012 Aug;56(8):4131-9 - PubMed
  6. Biochim Biophys Acta. 2006 Aug;1758(8):994-1003 - PubMed
  7. Ann N Y Acad Sci. 1974;238:543-51 - PubMed
  8. Clin Infect Dis. 2009 Nov 15;49(10):1541-9 - PubMed
  9. Curr Cardiol Rep. 2013 Apr;15(4):346 - PubMed
  10. NPJ Biofilms Microbiomes. 2016 Nov 23;2:2 - PubMed
  11. Trends Microbiol. 2001 Jan;9(1):34-9 - PubMed
  12. Adv Wound Care. 1996 Sep-Oct;9(5):42-5 - PubMed
  13. J Am Podiatr Med Assoc. 2014 Mar;104(2):147-53 - PubMed
  14. Annu Rev Microbiol. 2003;57:395-418 - PubMed
  15. J Wound Care. 2008 Nov;17(11):502-8 - PubMed
  16. Mol Ther. 2006 Jan;13(1):211-20 - PubMed
  17. Nature. 2008 Feb 21;451(7181):990-3 - PubMed
  18. New Microbiol. 2010 Apr;33(2):137-45 - PubMed
  19. J Int Med Res. 2009 Sep-Oct;37(5):1528-42 - PubMed
  20. J Immunol. 2011 Jun 1;186(11):6585-96 - PubMed
  21. South Med J. 1969 Jul;62(7):795-801 - PubMed
  22. Nat Biotechnol. 2005 Nov;23(11):1378-9 - PubMed
  23. Curr Opin Microbiol. 2013 Oct;16(5):580-9 - PubMed
  24. Glob Chall. 2019 Mar 06;3(6):1800101 - PubMed
  25. Antimicrob Agents Chemother. 2013 Nov;57(11):5572-9 - PubMed
  26. ACS Appl Mater Interfaces. 2017 May 24;9(20):16890-16899 - PubMed
  27. Sci Rep. 2015 Oct 14;5:14908 - PubMed
  28. Invest Ophthalmol Vis Sci. 2011 Mar 25;52(3):1723-34 - PubMed
  29. Semin Cell Dev Biol. 2009 Aug;20(6):674-82 - PubMed
  30. PLoS One. 2013;8(2):e56846 - PubMed
  31. Exp Dermatol. 2011 Mar;20(3):229-31 - PubMed
  32. Biochem Biophys Res Commun. 2012 Jun 29;423(2):253-8 - PubMed
  33. Nat Rev Microbiol. 2011 Jan;9(1):62-75 - PubMed
  34. J Invest Dermatol. 2007 Mar;127(3):514-25 - PubMed
  35. J Dent Res. 2010 Mar;89(3):219-29 - PubMed
  36. J Antimicrob Chemother. 2012 Jul;67(7):1697-700 - PubMed
  37. ChemSusChem. 2013 Jul;6(7):1252-61 - PubMed
  38. Plast Reconstr Surg. 2011 Jan;127 Suppl 1:93S-102S - PubMed
  39. J Antimicrob Chemother. 2012 Jul;67(7):1589-96 - PubMed
  40. Biomaterials. 2014 Sep;35(27):7690-8 - PubMed
  41. J Infect Dis. 1995 Jan;171(1):216-9 - PubMed
  42. PeerJ. 2014 Mar 25;2:e326 - PubMed
  43. J Bacteriol. 2001 Dec;183(24):7182-9 - PubMed
  44. Biofouling. 2012;28(8):769-78 - PubMed
  45. PLoS One. 2012;7(11):e49215 - PubMed
  46. PLoS One. 2013 Nov 25;8(11):e81316 - PubMed
  47. J Hosp Infect. 1995 Sep;31(1):13-24 - PubMed
  48. Nat Rev Drug Discov. 2003 Feb;2(2):114-22 - PubMed
  49. Science. 1999 May 21;284(5418):1318-22 - PubMed
  50. Adv Mater. 2016 Jul;28(27):5470-84 - PubMed
  51. J Antimicrob Chemother. 2007 Aug;60(2):417-20 - PubMed
  52. Phys Chem Chem Phys. 2011 Dec 28;13(48):21573-84 - PubMed
  53. Ann N Y Acad Sci. 2011 Dec;1241:104-21 - PubMed
  54. J Med Microbiol. 2006 Jan;55(Pt 1):59-63 - PubMed
  55. Clin Pharmacol Ther. 2007 Aug;82(2):204-9 - PubMed

Publication Types

Grant support